ӳ����ý

The finding suggests a potentially more targeted way to treat certain patients with the disorder, called CHIP, which commonly affects the elderly

A large genetic study of venous thromboembolism could lead to better ways of identifying and treating people at high risk for the disease.

Calculating genetic risk scores for obesity, new insights about leukemia drugs, and more.

Powerful new tool may enable new opportunities for biological understanding and clinical interventions

Mutations in TTN, a gene associated with several forms of heart disease and heart failure, may also play key roles in early form of a common heart arrhythmia.

Learning more about lipid loci, and putting genetic-guided medicine to the test.

Looking at a brain tumor from all the angles, and what urine can teach us about heart disease risk.

Through “polygenic risk scoring,” researchers can identify people at high risk for disease, even if they don’t present other warning signs; method shows potential for use in the clinic